Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia

By Lundin Jeanette   Karlsson Claes   Celsing Fredrik  

Medical Oncology, Vol. 23, Iss. 1, 2006-03 ,pp. : 137-139

Humana Press, Inc

Access to resources Recommend Favorite

Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia

By Kaufman Matthew  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 532-538

Humana Press, Inc

Access to resources Recommend Favorite

Chronic lymphocytic leukemia

By Andritsos Leslie   Khoury Hanna  

Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. : 225-231

Springer Publishing Company

Access to resources Recommend Favorite

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina   Ösby Eva   Lundin Jeanette   Kalin Mats   Österborg Anders   Gruber Astrid  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite

BRAF mutations in chronic lymphocytic leukemia

By Jebaraj Billy Michael Chelliah  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1177-1182

Informa Healthcare

Access to resources Recommend Favorite